Hims & Hers Health (HIMS) stock moves a notch higher Monday morning after the company's weight-loss drug ad played during the Super Bowl. The commercial's airing raised concerns from health ...

Shares of Hims & Hers Health Inc. jumped nearly 4% in early premarket trading Monday, on track for fresh record highs, after the company aired a provocative Super Bowl ad that targeted Big Pharma ...

In a statement, Hims & Hers said the drug industry is trying to cancel an ad that "directly calls out how they are part of a system that fails to prioritize the health of Americans. The system is ...

Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site. The ad also hit a nerve with the pharma industry, lawmakers and some industry groups. The ad ...

Telehealth stock Hims & Hers (HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper GLP-1 weight-loss drugs sparked controversy. The ad criticized the ...

The reaction: Last week, Senators Richard Durbin, a Democrat, and Roger Marshall, a Republican, criticized Hims & Hers' ad, writing in a letter to the FDA that the company didn’t include the ...

Hims & Hers Health has undeniably captured market attention and investor enthusiasm, fueled by a successful Super Bowl ad campaign and its strategic entry into the high-demand GLP-1 weight loss ...